loadpatents
Patent applications and USPTO patent grants for Yang; Hanbiao.The latest application filed is for "cd73 inhibitors and uses thereof".
Patent | Date |
---|---|
Cd73 Inhibitors And Uses Thereof App 20210317150 - Wang; Bin ;   et al. | 2021-10-14 |
Compositions And Methods For Inhibiting Cd73 App 20210253614 - Wang; Bin ;   et al. | 2021-08-19 |
Aromatic compounds and uses thereof Grant 10,807,948 - Dixon , et al. October 20, 2 | 2020-10-20 |
Aryl Ethers And Uses Thereof App 20200190031 - Dixon; Darryl David ;   et al. | 2020-06-18 |
Cd73 Inhibitors And Uses Thereof App 20200115404 - WANG; Bin ;   et al. | 2020-04-16 |
Aryl ethers and uses thereof Grant 10,597,366 - Dixon , et al. | 2020-03-24 |
Aryl Ethers And Uses Thereof App 20190119214 - Dixon; Darryl David ;   et al. | 2019-04-25 |
Heterocyclic modulators of lipid synthesis and combinations thereof Grant 10,226,449 - Heuer , et al. | 2019-03-12 |
Heterocyclic modulators of lipid synthesis Grant 10,189,822 - Oslob , et al. Ja | 2019-01-29 |
Compositions for Use in Treating Pulmonary Arterial Hypertension App 20190015377 - Dixon; Darryl David ;   et al. | 2019-01-17 |
Substituted pyridines and uses thereof Grant 10,155,726 - Wehn , et al. Dec | 2018-12-18 |
Aryl ethers and uses thereof Grant 10,144,711 - Dixon , et al. De | 2018-12-04 |
Heterocyclic modulators of lipid synthesis Grant 10,118,913 - Oslob , et al. November 6, 2 | 2018-11-06 |
Heterocyclic modulators of lipid synthesis Grant 10,053,450 - Oslob , et al. August 21, 2 | 2018-08-21 |
Heterocyclic Modulators Of Lipid Synthesis App 20180222892 - OSLOB; Johan D. ;   et al. | 2018-08-09 |
Benzimidazole derivatives and uses thereof Grant 10,040,767 - Dixon , et al. August 7, 2 | 2018-08-07 |
Aromatic Compounds And Uses Thereof App 20180162807 - DIXON; Darryl David ;   et al. | 2018-06-14 |
Aryl Ethers And Uses Thereof App 20180155279 - Dixon; Darryl David ;   et al. | 2018-06-07 |
Substituted Pyridines And Uses Thereof App 20180148413 - Wehn; Paul ;   et al. | 2018-05-31 |
Aryl ethers and uses thereof Grant 9,969,689 - Dixon , et al. May 15, 2 | 2018-05-15 |
Heterocyclic Modulators Of Lipid Synthesis App 20180079746 - Oslob; Johan D. ;   et al. | 2018-03-22 |
Aryl ethers and uses thereof Grant 9,908,845 - Dixon , et al. March 6, 2 | 2018-03-06 |
Aryl ethers and uses thereof Grant 9,896,418 - Dixon , et al. February 20, 2 | 2018-02-20 |
Cyclic sulfone and sulfoximine analogs and uses thereof Grant 9,884,843 - Dixon , et al. February 6, 2 | 2018-02-06 |
Heterocyclic modulators of lipid synthesis Grant 9,809,591 - Oslob , et al. November 7, 2 | 2017-11-07 |
Tricyclic inhibitors of HIF-2-alpha and uses thereof Grant 9,796,697 - Wehn , et al. October 24, 2 | 2017-10-24 |
Aryl Ethers And Uses Thereof App 20170217892 - Dixon; Darryl David ;   et al. | 2017-08-03 |
Aryl Ethers And Uses Thereof App 20170217891 - Dixon; Darryl David ;   et al. | 2017-08-03 |
Heterocyclic modulators of lipid synthesis Grant 9,624,173 - Oslob , et al. April 18, 2 | 2017-04-18 |
Benzimidazole Derivatives And Uses Thereof App 20170088523 - DIXON; Darryl David ;   et al. | 2017-03-30 |
Cyclic Sulfone And Sulfoximine Analogs And Uses Thereof App 20160368893 - DIXON; Darryl David ;   et al. | 2016-12-22 |
Tricyclic Inhibitors Of Hif-2-alpha And Uses Thereof App 20160362390 - Wehn; Paul ;   et al. | 2016-12-15 |
Heterocyclic Modulators Of Lipid Synthesis And Combinations Thereof App 20160338998 - Heuer; Timothy Sean ;   et al. | 2016-11-24 |
Heterocyclic Modulators Of Lipid Synthesis App 20160311803 - Oslob; Johan D. ;   et al. | 2016-10-27 |
Aryl Ethers And Uses Thereof App 20160251307 - DIXON; Darryl David ;   et al. | 2016-09-01 |
Heterocyclic modulators of lipid synthesis Grant 9,428,502 - Oslob , et al. August 30, 2 | 2016-08-30 |
Heterocyclic Modulators Of Lipid Synthesis App 20160102091 - Oslob; Johan D. ;   et al. | 2016-04-14 |
Heterocyclic Modulators Of Lipid Synthesis App 20150259292 - Oslob; Johan D. ;   et al. | 2015-09-17 |
Heterocyclic Modulators Of Lipid Synthesis App 20150210688 - OSLOB; Johan D. ;   et al. | 2015-07-30 |
Heterocyclic Modulators Of Lipid Synthesis App 20140322355 - Oslob; Johan D. ;   et al. | 2014-10-30 |
Heterocyclic modulators of lipid synthesis Grant 8,871,790 - Oslob , et al. October 28, 2 | 2014-10-28 |
Macrocyclic inhibitors of JAK Grant 8,318,764 - Jahangir , et al. November 27, 2 | 2012-11-27 |
Heterocyclic Modulators of Lipid Synthesis App 20120264737 - Oslob; Johan D. ;   et al. | 2012-10-18 |
Pyrrolopyrazine kinase inhibitors Grant 8,008,298 - Bamberg , et al. August 30, 2 | 2011-08-30 |
Pyrrolopyrazine kinase inhibitors Grant 7,939,531 - Bamberg , et al. May 10, 2 | 2011-05-10 |
Macrocyclic Inhibitors Of Jak App 20110071179 - Jahangir; Alam ;   et al. | 2011-03-24 |
Pyrrolopyrazine kinase inhibitors Grant 7,902,197 - Elworthy , et al. March 8, 2 | 2011-03-08 |
Pyrrolopyrazine kinase inhibitors App 20100267666 - Bamberg; Joe Timothy ;   et al. | 2010-10-21 |
Heterocyclic antiviral compounds App 20090281133 - Rotstein; David Mark ;   et al. | 2009-11-12 |
Indane compounds as CCR5 antagonists Grant 7,589,204 - Youngman , et al. September 15, 2 | 2009-09-15 |
Pyrrolopyrazine kinase inhibitors App 20090215750 - Bamberg; Joe Timothy ;   et al. | 2009-08-27 |
Pyrrolopyrazine kinase inhibitors App 20090215788 - Elworthy; Todd Richard ;   et al. | 2009-08-27 |
Indane Compounds As Ccr5 Antagonists App 20090187021 - YOUNGMAN; Michael ;   et al. | 2009-07-23 |
Indane compounds as CCR5 antagonists Grant 7,531,661 - Youngman , et al. May 12, 2 | 2009-05-12 |
Heterocyclic antiviral compounds App 20090093501 - Gabriel; Stephen Deems ;   et al. | 2009-04-09 |
Pyrrolidine and azetidine compounds as CCR5 antagonists Grant 7,271,172 - Yang , et al. September 18, 2 | 2007-09-18 |
Pyrrolidine and azetidine compounds as ccr5 antagonists App 20060058284 - Yang; Hanbiao ;   et al. | 2006-03-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.